HUMAN CHORIONIC GONADOTROPIN BETA (BHCG) - TUMOR MARKER/CONGENITAL DISORDERS - ANVISA Registration 80254180476

Access comprehensive regulatory information for HUMAN CHORIONIC GONADOTROPIN BETA (BHCG) - TUMOR MARKER/CONGENITAL DISORDERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180476 and manufactured by B-R-A-H-M-S GMBH. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Mar 05, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, AUTOBIO DIAGNOSTICS CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.